Nektar Therapeutics shares fall on secondary stock offering
October 19, 2016 at 11:31 AM EDT
Nektar Therapeutics dropped Wednesday after the biotech company announced a secondary offering of common stock worth more than $175 million.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.